The NFL has chosen to work with BioReference Laboratories in testing players and staff for the upcoming NFL season. The move comes after several star players blitzed the league on Twitter, criticizing the NFL's lack of direction heading into camp. This is the third professional sports contract that BioReference has announced this month, and now the stock of their parent company, OPKO Health, flirted with all-time highs during Tuesday's session. Within the last two weeks, the company revealed that it will provide COVID-19 testing for the NBA and MLS. Mark Carman, studio host for Fansided, discusses his reaction to the NFL's plan as teams are set to arrive at training camp.